Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Medicinal Chemicals & Botanical Products

Standard Industrial Classification: SIC 2833

Industry Insider Sentiment Analysis

The Medicinal Chemicals & Botanical Products sector (SIC 2833) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2011-03-09 18:58 2011-03-04 HENC Hero Technologies Inc. Stevenson Mark E. Director, Officer, 10% owner BUY $0.15 166,667 $25,000 48,275,102
2011-03-09 18:45 2011-03-04 HENC Hero Technologies Inc. Prim Eric C Director, Officer BUY $0.15 166,667 $25,000 48,385,362
2011-03-09 18:51 2011-03-04 HENC Hero Technologies Inc. WESOLEK ROBERT Officer BUY $0.15 66,667 $10,000 2,912,500
2011-03-10 03:14 2011-03-07 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $3.60 23,950 $86,225 304,722
2011-03-01 03:55 2011-02-25 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $3.27 9,109 $29,818 280,772
2011-03-01 03:51 2011-02-24 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $3.31 25,000 $82,628 271,663
2011-02-11 20:11 2011-02-09 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $35.00 7,000 $245,000 7,998,040
2011-02-11 20:12 2011-02-09 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $35.00 7,000 $245,000 7,998,040
2011-02-08 21:26 2011-02-04 CDXC-OB Niagen Bioscience, Inc. FROST PHILLIP MD ET AL 10% owner BUY $1.53 5,000 $7,670 7,575,002
2011-02-04 23:52 2011-02-02 CDXC-OB Niagen Bioscience, Inc. FROST PHILLIP MD ET AL 10% owner BUY $1.58 10,000 $15,810 7,570,002
2011-02-02 22:49 2011-01-31 CDXC-OB Niagen Bioscience, Inc. FROST PHILLIP MD ET AL 10% owner BUY $1.63 10,000 $16,280 7,560,002
2011-01-31 22:06 2011-01-27 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $40.01 2,000 $80,020 171,677
2011-01-15 03:10 2011-01-12 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $42.50 7,000 $297,500 8,005,040
2011-01-15 03:11 2011-01-12 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $42.50 7,000 $297,500 8,005,040
2011-01-15 01:27 2011-01-14 MTEX MANNATECH INC JOBE LARRY A Director BUY $1.93 10,000 $19,335 30,000
2011-01-03 17:53 2009-08-20 BNLB-OB FITLIFE BRANDS, INC. LANDERS ELORIAN CONNARD Director SELL $0.66 21,500 $14,270 446,500
2011-01-03 17:53 2009-08-17 BNLB-OB FITLIFE BRANDS, INC. LANDERS ELORIAN CONNARD Director BUY $0.38 21,000 $8,035 450,500
2010-12-27 19:57 2010-12-23 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $43.75 2,000 $87,500 173,677
2010-12-17 22:50 2010-12-15 XELR-OB Charlie's Holdings, Inc. GREENBERG SANFORD D 10% owner BUY $0.20 15,000 $3,000 3,631,406
2010-12-15 21:34 2010-12-08 CDXC-OB Niagen Bioscience, Inc. Jaksch Frank L Jr Director, Officer, 10% owner BUY $1.50 5,000 $7,500 5,000
2010-12-14 01:12 2010-12-09 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $3.02 5,214 $15,760 246,663
2010-12-14 02:58 2010-12-10 NAII NATURAL ALTERNATIVES INTERNATIONAL INC LEDOUX MARK A Director, Officer, 10% owner SELL $6.75 5,000 $33,752 561,851
2010-12-10 23:07 2010-12-08 CDXC-OB Niagen Bioscience, Inc. Brauser Michael Director, 10% owner BUY $1.52 5,000 $7,590 2,152,856
2010-12-10 21:15 2010-12-08 USNA USANA HEALTH SCIENCES INC POELMAN RONALD S Director OPT+S $44.06 15,000 $660,914 5,000
2010-12-09 21:26 2010-12-08 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $42.08 10,500 $441,840 8,012,040
2010-12-09 21:27 2010-12-08 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $42.08 10,500 $441,840 8,012,040
2010-12-10 04:10 2010-12-08 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $2.93 21,346 $62,623 241,449
2010-12-10 04:09 2010-12-07 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $3.01 12,944 $38,996 220,103
2010-12-03 21:04 2010-12-01 NAII NATURAL ALTERNATIVES INTERNATIONAL INC WELDON LEE G Director SELL $6.80 5,000 $34,008 45,741
2010-11-27 00:13 2010-11-26 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $43.10 2,000 $86,200 175,677
2010-11-24 20:58 2010-11-22 CDXC-OB Niagen Bioscience, Inc. Brauser Michael Director, 10% owner BUY $1.60 5,000 $8,000 2,147,856
2010-11-23 18:53 2010-11-18 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer OPT+S $44.19 100,000 $4,419,000 177,677
2010-11-23 05:11 2010-11-18 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $2.84 39,321 $111,766 50,000
2010-11-23 05:10 2010-11-18 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $2.88 45,596 $131,531 207,159
2010-11-19 01:08 2010-11-16 CYAN CYANOTECH CORP DAVIS MICHAEL A / Director, 10% owner BUY $2.60 10,679 $27,749 10,679
2010-11-12 18:06 2010-11-10 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $43.51 10,500 $456,855 8,022,540
2010-11-12 18:07 2010-11-10 USNA USANA HEALTH SCIENCES INC WENTZ MYRON W Director SELL $43.51 10,500 $456,855 8,022,540
2010-11-09 19:34 2010-11-05 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $44.52 10,000 $445,200 177,677
2010-11-05 00:45 2010-11-02 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $44.26 39,532 $1,749,876 187,677
2010-11-03 00:51 2010-11-02 USNA USANA HEALTH SCIENCES INC Bramble James Officer OPT+S $44.06 2,909 $128,171 0
2010-11-02 01:58 2010-10-28 USNA USANA HEALTH SCIENCES INC Yates Jeffrey Officer OPT+S $44.81 12,430 $556,988 0
2010-11-02 02:20 2010-10-28 USNA USANA HEALTH SCIENCES INC Woo Deborah Officer OPT+S $44.94 1,550 $69,657 0
2010-11-02 02:13 2010-10-28 USNA USANA HEALTH SCIENCES INC Truett Roy Officer OPT+S $44.80 17,618 $789,286 0
2010-11-02 02:10 2010-10-28 USNA USANA HEALTH SCIENCES INC Guest Kevin Officer OPT+S $44.67 65,742 $2,936,662 0
2010-11-02 02:06 2010-10-28 USNA USANA HEALTH SCIENCES INC WILSON MARK H Officer OPT+S $44.79 29,742 $1,332,144 5,000
2010-11-02 01:54 2010-10-28 USNA USANA HEALTH SCIENCES INC COOPER FRED W Officer OPT+S $44.80 32,228 $1,443,814 0
2010-11-02 02:02 2010-10-28 USNA USANA HEALTH SCIENCES INC WOOD TIMOTHY E Officer OPT+S $44.94 13,666 $614,150 27,500
2010-11-02 01:55 2010-10-28 USNA USANA HEALTH SCIENCES INC WENTZ DAVE Officer SELL $44.46 2,000 $88,920 227,209
2010-11-02 02:18 2010-10-28 USNA USANA HEALTH SCIENCES INC MCCLAIN JERRY G Director OPT+S $44.46 1,000 $44,460 200
2010-10-16 01:49 2010-10-13 USNA USANA HEALTH SCIENCES INC GULL HOLDINGS LTD 10% owner SELL $40.06 3,500 $140,210 8,033,040
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Medicinal Chemicals & Botanical Products sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2833) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Medicinal Chemicals & Botanical Products

Every transaction in the Medicinal Chemicals & Botanical Products industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.